Platelet-vessel wall interactions: implication of 5-hydroxytryptamine. A review

Agents and Actions
F De ClerckR S Reneman

Abstract

The evidence for an impact of platelet-derived 5-hydroxytryptamine (5-HT) on local tissue perfusion is reviewed. By interacting with 5-HT2 serotonergic receptors, 5-HT, directly or through amplification, activates platelets, endothelial and vascular smooth muscle cells producing platelet aggregation, vascular permeability increase and large vessel constriction. Pharmacodissection in experimental animals with selective serotonergic 5-HT2 receptor antagonists, e.g. ketanserin, shows that 5-HT largely contributes to the platelet-mediated increase in vascular permeability, to platelet-vessel wall interaction during hemostasis, to cardiopulmonary dysfunction provoked by thromboembolism and to the platelet-mediated inhibition of peripheral collateral circulation. Clinical results obtained with ketanserin further substantiate an involvement of platelet-derived 5-HT in the pathogenesis of impaired tissue perfusion in some cardiovascular conditions.

References

Aug 9, 1975·Lancet·C A LudlamJ D Cash
Jul 30, 1977·Lancet·C W RedmanG M Stirrat
Feb 4, 1978·Lancet·A W BurrowsT D Hockaday
Aug 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·M I SiegelP Cuatrecasas
May 17, 1979·The New England Journal of Medicine·S Moncada, J R Vane
Jan 1, 1978·British Journal of Obstetrics and Gynaecology·K A WhighamC R Prentice
Nov 1, 1975·Clinical Orthopaedics and Related Research·R S Reneman
Feb 15, 1988·Experientia·D de Chaffoy de CourcellesF de Clerck
Jul 1, 1985·Pharmacological Research Communications·J M Van NuetenP M Vanhoutte
Jul 1, 1985·Microvascular Research·D H Hechtman, A Jageneau
Mar 1, 1972·The Journal of Clinical Investigation·R L NachmanB Ferris
Aug 1, 1965·Proceedings of the Society for Experimental Biology and Medicine·J F MustardA Sényi
Apr 1, 1970·Proceedings of the Society for Experimental Biology and Medicine·K UdakaH Z Movat
Oct 1, 1968·The Australian Journal of Experimental Biology and Medical Science·G C Scroop, J A Walsh
Sep 1, 1965·The American Journal of Physiology·B M Altura, B W Zweifach
Aug 1, 1969·The Journal of Pathology·A M Northover, B J Northover
Feb 1, 1970·The Journal of Clinical Investigation·R L NachmanB Ferris
Nov 1, 1970·Proceedings of the Society for Experimental Biology and Medicine·G GabbianiG Majno
Mar 1, 1968·Biochemical Pharmacology·M A PackhamJ F Mustard
Jul 1, 1968·Journal of Atherosclerosis Research·A PoplawskiS Niewiarowski
Sep 1, 1969·The Journal of Cell Biology·G MajnoM Leventhal
Jul 30, 1982·European Journal of Pharmacology·R M Brazenor, J A Angus
Nov 1, 1981·Journal of Cardiovascular Pharmacology·F De Clerck, J L David
Mar 1, 1982·Circulation Research·S I Said
Jan 1, 1983·European Journal of Obstetrics, Gynecology, and Reproductive Biology·J I de VriesJ G Aarnoudse
Jan 1, 1984·Journal of Cardiovascular Pharmacology·J M Van NuetenP M Vanhoutte
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S E DahlénB Samuelsson
Jan 1, 1983·Prostaglandins, Leukotrienes, and Medicine·S B Acharya, D E MacIntyre
Dec 15, 1983·Biochemical Pharmacology·P M Vanhoutte, R A Cohen
Mar 1, 1983·Biochemical Pharmacology·F De Clerck, J M Van Nueten

❮ Previous
Next ❯

Citations

Jan 1, 1993·European Journal of Clinical Pharmacology·G GleerupK Winther
Dec 1, 1985·Agents and Actions·F de ClerckR van de Wiele
Jul 15, 1996·Thrombosis Research·D PawlakM Mysliwiec
Sep 1, 1996·Thrombosis Research·J MalyszkoM Mysliwiec
Jan 1, 1988·Molecular Aspects of Medicine·N C OlsonC E McCall
Jan 1, 1991·General Pharmacology·A L López de PabloM V Conde
Jun 26, 1998·Clinica Chimica Acta; International Journal of Clinical Chemistry·N K GolovanovaL D Bergelson
Sep 21, 2000·Transplantation Proceedings·N NakamuraY Moriyama
Nov 15, 2000·Bioorganic & Medicinal Chemistry Letters·M FujioY Matsumoto
Jun 10, 2000·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·T OgawaH Koike
May 1, 1996·International Journal of Urology : Official Journal of the Japanese Urological Association·S MugiyaA Takada
Sep 11, 2007·The Journal of Surgical Research·Andreas WaltherEike Martin
Aug 1, 1994·Journal of Cardiothoracic and Vascular Anesthesia·P J Van der Starre, R S Reneman
Jul 22, 1999·Archives of Oral Biology·K TominagaS Kopp
Oct 15, 1994·Thrombosis Research·D UedaK Kawabe
Feb 1, 1987·International Journal of Cardiology·A Pletscher
Sep 20, 2005·Journal of Pharmacological and Toxicological Methods·Scott R ArmstrongDavid T Beattie
Nov 2, 2001·Journal of Critical Care·A WaltherH Schmidt
May 20, 2004·The Annals of Pharmacotherapy·Rajamannar Ramasubbu
Apr 1, 1988·Stroke; a Journal of Cerebral Circulation·P TurcániB Mihara
Oct 1, 1989·Stroke; a Journal of Cerebral Circulation·R JosephG D'Andrea
Jan 1, 1989·American Journal of Primatology·Douglas M BowdenDarrell D Williams
Nov 10, 1987·European Journal of Pharmacology·M HirafujiY Ogura

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.